Cytochrome P-450 Monooxygenases and Interactions of Psychotropic Drugs
- 1 March 1991
- journal article
- review article
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 21 (1), 47-56
- https://doi.org/10.2190/u0bd-pvhw-ba01-a1d0
Abstract
The authors review drug biotransformation. Phase I reactions are preconjugation processes that take place through cytochrome P-450—a hepatic mixed function oxidase (MFO) enzyme system with multiple isozymes to metabolize foreign substances. Phase II reactions are conjugation processes of the substrates. Based on the characteristics of the cytochrome P-450 microsomal enzyme systems, the authors explain the clinical phenomena of induction and inhibition of these enzymes when psychotropic agents interact. This article describes both MFO inducers (barbiturates) and inhibitors (cimeditine, fluoxetine and neuroleptic drugs). With this information, clinicians can enhance the ability to monitor drug interactions of psychotropic agents.Keywords
This publication has 36 references indexed in Scilit:
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1989
- Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?American Journal of Psychiatry, 1986
- Plasma Level Monitoring of Antipsychotic Drugs Clinical UtilityClinical Pharmacokinetics, 1986
- Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophreniaBiological Psychiatry, 1985
- Drug Level Monitoring in PsychopharmacologyTherapeutic Drug Monitoring, 1982
- Drug interactions involving psychotropic drugsPsychosomatics, 1978
- Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.British Journal of Clinical Pharmacology, 1975
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1975
- THE EFFECT OF FLUPHENAZINE ON STEADY STATE PLASMA LEVELS OF NORTRIPTYLINEBritish Journal of Clinical Pharmacology, 1974
- Factors Affecting Chlorpromazine Plasma Levels in Psychiatric PatientsArchives of General Psychiatry, 1970